Pharmacokinetic Interactions of the Microsomal Triglyceride Transfer Protein Inhibitor, Lomitapide, with Drugs Commonly Used in the Management of Hypercholesterolemia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacokinetic Interactions of the Microsomal Triglyceride Transfer Protein Inhibitor, Lomitapide, with Drugs Commonly Used in the Management of Hypercholesterolemia

Published:2013-10-15 Issue:3 Volume:34 Page:227-239
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Tuteja Sony¹,Duffy Danielle²,Dunbar Richard L.¹,Movva Rajesh¹,Gadi Ram¹,Bloedon LeAnne T.³,Cuchel Marina¹

Affiliation:

1. Institute for Translational Medicine and Therapeutics; University of Pennsylvania School of Medicine; Philadelphia Pennsylvania

2. Jefferson Medical College; Division of Cardiology; Philadelphia Pennsylvania

3. Aegerion Pharmaceuticals Inc.; Cambridge Massachusetts

Publisher

Wiley

Subject

Pharmacology (medical)

Reference30 articles.

1. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III);Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III);JAMA,2001

2. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines;Grundy;Circulation,2004

3. Lomitapide (Juxtapid) U.S. prescribing information 2012

4. MTP inhibition as a treatment for dyslipidaemias: time to deliver or empty promises?;Burnett;Expert Opin Ther Targets,2007

5. Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia;Cuchel;N Engl J Med,2007

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug interactions in cardiology: focus on statins and their combination with other lipid-lowering drugs;Expert Opinion on Drug Metabolism & Toxicology;2024-09-13

2. Research Progress in the Clinical Treatment of Familial Hypercholesterolemia;Current Medicinal Chemistry;2024-03

3. Brief Overview of Statins for Lowering Low-Density Lipid Cholesterol;Pharmacy Information;2024

4. Atualização da Diretriz Brasileira de Hipercolesterolemia Familiar – 2021;Arquivos Brasileiros de Cardiologia;2021-09-27

5. A quantitative systems pharmacology modeling platform for evaluating triglyceride profiles in patients with high triglycerides receiving evinacumab;CPT: Pharmacometrics & Systems Pharmacology;2021-08-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3